Examination of Lower Urinary System Symptoms With Duchenne Muscular Dystrophy

Sponsor
Lokman Hekim Üniversitesi (Other)
Overall Status
Completed
CT.gov ID
NCT05464446
Collaborator
Hacettepe University (Other)
45
1
8.6
5.2

Study Details

Study Description

Brief Summary

The aim of this study is to examine the prevalence of lower urinary tract symptoms (LUTS) in children with Duchenne Muscular Dystrophy (DMD) and the relationship between functional level, posture, muscle strength, pelvic floor muscle control, participation in activities of daily living, and quality of life that may be associated with these symptoms.

Forty-five children with DMD between the ages of 5-18 (Age: 9.00±3.32 years, Weight:

31,10±12,59 kg, Height: 125,87±18,46 cm) and their families were included in the study. LUTS was assessed with Dysfunctional Voiding And Incontinence Scoring System, functional level with Brooke Upper Extremity Functional Classification and Vignos Scale, posture with the New York Posture Assessment Questionnaire, Baseline Bubble Inclinometer (10602, Fabrication Enterprises Inc. New York, USA) and Baseline Digital Inclinometer (12-1057, Fabrication Enterprises Inc, New York, USA), participation in activities of daily living was assessed with the Barthel Index and quality of life was assessed with the Pediatric Quality of Life Inventory 3.0 Neuromuscular Module. Also, using the Hoggan microFET2 (Hoggan Scientific, LLC, Salt Lake City UT, USA) device, hip flexors, quadriceps femoris muscles, shoulder flexors, elbow extensors, elbow flexors, trunk extensors and flexors were evaluated in terms of muscle strength. Evaluations were made once, and the associated factors were compared in the group with and without LUTS, and the relationship between the factors and the severity of LUTS was examined.

Condition or Disease Intervention/Treatment Phase
  • Device: Baseline Bubble Inclinometer, Baseline Digital İnclinometer and Hoggan microFET2 devices

Study Design

Study Type:
Observational
Actual Enrollment :
45 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Examination of Lower Urinary System Symptoms and Related Factors in Children With Duchenne Muscular Dystrophy
Actual Study Start Date :
Oct 1, 2021
Actual Primary Completion Date :
Jun 1, 2022
Actual Study Completion Date :
Jun 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Duchenne Muscular Dystrophy

Children with Duchenne Muscular Dystrophy (DMD) between the ages of 5 and 18 who were diagnosed with DMD by a specialist physician as a result of gene analysis and/or muscle biopsy and their families were included in the study.

Device: Baseline Bubble Inclinometer, Baseline Digital İnclinometer and Hoggan microFET2 devices
Bubble inclinometer was used to measure lumbar lordosis angle, Digital inclinometer was used to measure pelvic inclination angle and Hoggan microFET2 was used for muscle strength measurement.

Outcome Measures

Primary Outcome Measures

  1. Lower urinary system symptoms [1 hour]

    It will be investigated how many of the children with DMD participating in the study will have lower urinary system symptoms.

  2. Lower urinary system dysfunction [1 hour]

    It will be investigated how many of the children with DMD participating in the study will have lower urinary system dysfunction.

  3. Muscle strength and lower urinary system symptoms [1 hour]

    It will be investigated whether there is a relationship between lower urinary tract symptoms and muscle strength in children with DMD.

  4. Functionality and lower urinary system symptoms [1 hour]

    It will be investigated whether there is a relationship between lower urinary tract symptoms and functionality in children with DMD.

  5. Posture and lower urinary system symptoms [1 hour]

    It will be investigated whether there is a relationship between lower urinary tract symptoms and posture in children with DMD.

  6. Pelvic floor muscle control and lower urinary system symptoms [1 hour]

    It will be investigated whether there is a relationship between lower urinary tract symptoms and pelvic floor muscle control in children with DMD.

  7. Activities of daily living and lower urinary system symptoms [1 hour]

    It will be investigated whether there is a relationship between lower urinary tract symptoms and activities of daily living in children with DMD.

  8. Quality of life and lower urinary system symptoms [1 hour]

    It will be investigated whether there is a relationship between lower urinary tract symptoms and quality of life in children with DMD.

Secondary Outcome Measures

  1. Urologist evaluation [1 hour]

    It will investigate whether children with DMD have ever been to a urologist in their life.

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 18 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Having been diagnosed with DMD by a specialist physician as a result of gene analysis and/or muscle biopsy,

  • Being between the ages of 5-18,

  • Volunteering by parents to participate in the study and reading and signing the informed consent form.

Exclusion Criteria:
  • Having a diagnosed neuromuscular disease other than DMD and/or with DMD,

  • Having a diagnosed psychiatric and/or metabolic disease,

  • Having a diagnosis of autism spectrum disorders,

  • Presence of congenital and/or acquired anomalies that may affect communication,

  • The family and/or the child has a problem of cooperation in completing the assessments for any reason,

  • Using a catheter and/or a diaper all day,

  • Having difficulty in understanding and speaking the Turkish language.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lokman Hekim University Ankara Turkey 6510

Sponsors and Collaborators

  • Lokman Hekim Üniversitesi
  • Hacettepe University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Demet Öztürk, Research Assistant, Lokman Hekim Üniversitesi
ClinicalTrials.gov Identifier:
NCT05464446
Other Study ID Numbers:
  • 16969557-1784
First Posted:
Jul 19, 2022
Last Update Posted:
Jul 19, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2022